Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,500
Stocks News & Analysis
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,196.80 | 20.60 | -0.22% |
CAC 40 | 7,706.18 | 2.28 | 0.03% |
DAX 40 | 23,975.65 | 73.44 | 0.31% |
Dow JONES (US) | 45,544.88 | 92.02 | -0.20% |
FTSE 100 | 9,198.61 | 11.27 | 0.12% |
HKSE | 25,617.42 | 539.80 | 2.15% |
NASDAQ | 21,455.55 | 249.61 | -1.15% |
Nikkei 225 | 42,188.79 | 529.68 | -1.24% |
NZX 50 Index | 13,070.45 | 139.72 | 1.08% |
S&P 500 | 6,460.26 | 41.60 | -0.64% |
S&P/ASX 200 | 8,927.70 | 21.10 | -0.24% |
SSE Composite Index | 3,875.53 | 17.60 | 0.46% |